We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
76
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$179M 0.23%
1,548,361
+22,812
+1% +$2.53M
KMB icon
77
Kimberly-Clark
KMB
$36.5B
$177M 0.23%
1,289,147
+9,459
+0.7% +$1.28M
ABT icon
78
Abbott
ABT
$187B
$177M 0.22%
2,037,242
+53,283
+3% +$4.46M
COST icon
79
Costco
COST
$420B
$175M 0.22%
596,174
+24,286
+4% +$7.22M
PM icon
80
Philip Morris
PM
$295B
$175M 0.22%
2,057,054
-53,488
-3% -$4.41M
DUK icon
81
Duke Energy
DUK
$97.3B
$175M 0.22%
1,917,876
-3,399
-0.2% -$312K
FVD icon
82
First Trust Value Line Dividend Fund
FVD
$8.41B
$174M 0.22%
4,840,481
+823,484
+20% +$29M
NVDA icon
83
NVIDIA
NVDA
$5.42T
$174M 0.22%
29,578,320
+143,320
+0.5% +$745K
LHX icon
84
L3Harris
LHX
$53.4B
$174M 0.22%
877,518
+11,656
+1% +$2.34M
BND icon
85
Vanguard Total Bond Market
BND
$158B
$171M 0.22%
2,038,678
-7,292
-0.4% -$613K
GILD icon
86
Gilead Sciences
GILD
$165B
$170M 0.22%
2,610,917
-82,573
-3% -$5.38M
TGT icon
87
Target
TGT
$68B
$169M 0.22%
1,321,586
-137,221
-9% -$16.1M
BMY icon
88
Bristol-Myers Squibb
BMY
$132B
$165M 0.21%
2,575,273
+502,211
+24% +$28.8M
GSK icon
89
GSK
GSK
$106B
$165M 0.21%
2,811,427
+64,511
+2% +$3.59M
VEA icon
90
Vanguard FTSE Developed Markets ETF
VEA
$236B
$164M 0.21%
3,725,701
-27,865
-0.7% -$1.19M
NEE icon
91
NextEra Energy
NEE
$177B
$163M 0.21%
2,686,292
+143,704
+6% +$8.39M
TXN icon
92
Texas Instruments
TXN
$261B
$162M 0.21%
1,264,231
+23,470
+2% +$2.9M
USB icon
93
US Bancorp
USB
$99.6B
$162M 0.21%
2,733,688
+33,492
+1% +$1.94M
RTX icon
94
RTX Corp
RTX
$301B
$162M 0.21%
1,714,351
+57,720
+3% +$5.24M
EFA icon
95
iShares MSCI EAFE ETF
EFA
$80.2B
$160M 0.2%
2,307,370
+211,497
+10% +$14.3M
VIG icon
96
Vanguard Dividend Appreciation ETF
VIG
$114B
$159M 0.2%
1,275,398
+66,544
+6% +$8.05M
BDX icon
97
Becton Dickinson
BDX
$48.2B
$157M 0.2%
592,161
-7,242
-1% -$1.81M
ADSK icon
98
Autodesk
ADSK
$52.6B
$148M 0.19%
804,854
-21,969
-3% -$3.56M
VTV icon
99
Vanguard Morningstar Value ETF
VTV
$191B
$147M 0.19%
1,222,838
+51,778
+4% +$5.98M
XLV icon
100
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$146M 0.18%
1,428,479
+169,254
+13% +$16.3M

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.